NUVISAN The Science CRO

Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital...

Target identification,2d/3d modeling,bioinformatics,compound libraries,high-throughput screening,pharmacology,structural biology,fragment-based drug design,computational chemistry,hit-to-lead optimization,in vitro & in vivo dmpk,api manufacturing,radiosynthesis/isotope labeling,small & large molecule bioanalysis,immunogenicity testing,biomarker analysis & discovery,qp services,in-house clinical pharmacology unit,clinical & medical monitoring,clinical development,chemistry,and r&d innovation

Nuvisan the science cro operates in the Pharmaceutical manufacturing industry.

Nuvisan the science cro's revenue is 11m - 100m

Nuvisan the science cro has 501 - 1000 employees.